Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 8/20 | 0.67 |
| ▸ | FFAR1 | O14842 | 3/20 | 0.59 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.59 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | LCK | P06239 | 1/20 | 0.48 |
| ▸ | PPARD | Q03181 | 1/20 | 0.48 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.48 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.48 |
| ▸ | FAAH | O00519 | 2/20 | 0.47 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2066622 | 0.88 | GPR84 (0.51) | GPR84FFAR1FFAR4MAPTLCK | |
| SCHEMBL11967105 | 0.87 | GPR84 (0.59) | GPR84FFAR1FFAR4FAAH | |
| SCHEMBL15527770 | 0.84 | FFAR1 (0.68) | GPR84FFAR1FFAR4FAAH | |
| SCHEMBL19693898 | 0.84 | FFAR1 (0.68) | GPR84FFAR1FFAR4FAAH | |
| SCHEMBL28022735 | 0.83 | GPR84 (0.52) | GPR84FFAR1FFAR4MAPTLCK | |
| SCHEMBL28022723 | 0.83 | GPR84 (0.52) | GPR84FFAR1FFAR4MAPTLCK | |
| SCHEMBL9457090 | 0.83 | GPR84 (0.54) | GPR84FFAR1FFAR4FAAH | |
| SCHEMBL7101917 | 0.83 | GPR84 (0.54) | GPR84FFAR1FFAR4FAAH | |
| SCHEMBL28769950 | 0.83 | GPR84 (0.54) | GPR84FFAR1FFAR4FAAH | |
| SCHEMBL27506299 | 0.83 | GPR84 (0.54) | GPR84FFAR1FFAR4FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2203434-B1 | METHOD OF PREPARING (6R)-3-HEXYL-4-HYDROXY-6-UNDECYL-5,6-DIHYDROPYRAN-2-ONE, AND INTERMEDIATE USED IN THE METHOD | HANMI HOLDINGS CO LTD (KR) | 2012-08-29 | — | — | EP | disclosed |
| US-8242288-B2 | Method of preparing (6R)-3-hexyl-4-hydroxy-6-undecyl-5, 6-dihydropyran-2-one, and intermediate used in the method | HANMI HOLDINGS CO., LTD. (KR) | 2012-08-14 | — | — | US | disclosed |
| US-20100274029-A1 | METHOD OF PREPARING (6R)-3-HEXYL-4-HYDROXY-6-UNDECYL-5, 6-DIHYDROPYRAN-2-ONE, AND INTERMEDIATE USED IN THE METHOD | HANMI PHARM. CO., LTD. (KR) | 2010-10-28 | — | — | US | disclosed |
| EP-2203434-A2 | METHOD OF PREPARING (6R)-3-HEXYL-4-HYDROXY-6-UNDECYL-5,6-DIHYDROPYRAN-2-ONE, AND INTERMEDIATE USED IN THE METHOD | Hanmi Pharm. Co., Ltd. (KR) | 2010-07-07 | — | — | EP | disclosed |
| WO-2009057938-A2 | METHOD OF PREPARING (6R)-3-HEXYL-4-HYDROXY-6-UNDECYL-5,6-DIHYDROPYRAN-2-ONE, AND INTERMEDIATE USED IN THE METHOD | HANMI PHARM. CO., LTD. (KR) | 2009-05-07 | — | — | WO | disclosed |
| EP-1127886-B1 | Synthesis of 3,6-dialkyl-5,6-dihydro-4-hydroxy-2H-pyran-2one | HOFFMANN LA ROCHE (CH) | 2003-05-07 | — | — | EP | disclosed |
| US-6552204-B1 | Lactonization of an acyl halide and a ketene acetal or reacting acyl halide with malonate half acid then cyclizing; high yield | ROCHE COLORADO CORPORATION | 2003-04-22 | — | — | US | disclosed |
| CN-1319596-A | Synthesis of 3,6-dialkyl 5,6-dihydro-4-hydroxide-2H-pyran-2-ketone | HOFFMANN LA ROCHE (CH) | 2001-10-31 | — | — | CN | disclosed |
| EP-1127886-A1 | Synthesis of 3,6-dialkyl-5,6-dihydro-4-hydroxy-2H-pyran-2one | F. HOFFMANN-LA ROCHE AG (CH) | 2001-08-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100274029-A1 | METHOD OF PREPARING (6R)-3-HEXYL-4-HYDROXY-6-UNDECYL-5, 6-DIHYDROPYRAN-2-ONE, AND INTERMEDIATE USED IN THE METHOD | DHCR7, DHPS, CYP8B1 | GPR84 4041/4885FFAR1 179/4885FFAR4 182/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.